{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-100636","form_type":"8-K","ticker":"CGC","cik":"0001737927","company_name":"Canopy Growth Corp","filed_at":"2023-09-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.048473+00:00","generated_at":"2026-06-10T17:43:00.580139+00:00","sec_items":["2.05","2.06","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Canopy Growth ceases BioSteel funding; BioSteel files for creditor protection","bullets":["BioSteel entered CCAA creditor protection; Canopy Growth ceased funding, cutting ~60% of Q1 FY2024 Adj. EBITDA loss.","Expected total charges: CDN$15-20M exit costs and CDN$100-130M asset impairment in Q2 FY2024.","Annual cash savings estimated at >CDN$100M from eliminating BioSteel cash burn.","Reaffirms target of positive Adjusted EBITDA across remaining business units exiting FY2024.","Reduced debt by CAD$349M since July 1, 2023; sold Hershey Drive facility for CAD$53M."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-100636","json":"https://secwatch.observer/filing/0001104659-23-100636.json","markdown":"https://secwatch.observer/filing/0001104659-23-100636.md","text":"https://secwatch.observer/filing/0001104659-23-100636.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737927/000110465923100636/0001104659-23-100636-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737927/000110465923100636/tm2326136d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T17:43:00.580139+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"07754a0241f7b5eb389a3a69d034e77320788275","claim":"Canopy Growth Corp announced a restructuring with charges of The Company expects to incur charges of between CDN$15-20 million, of which the Company expects approximately CDN$3.7 million will consist of payroll-related ch affecting BioSteel Sports Nutrition Inc. and its affiliates (terminating, effective, as applicable, commencing September 14, 2023 and on an ongoing basis, 181 employees who were emp).","evidence_excerpt":"the entire workforce thereof was employed by the Company and will receive termination benefits and severance, as applicable. The Company expects to incur charges of between CDN$15-20 million, of which the Company expects approximately CDN$3.7 million will consist of payroll-related charges to be paid by the Company or Canopy Growth USA. The remaining","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737927/000110465923100636/0001104659-23-100636-index.htm","confidence":0.95,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"The Company expects to incur charges of between CDN$15-20 million, of which the Company expects approximately CDN$3.7 million will consist of payroll-related ch"},{"label":"Affected area","value":"BioSteel Sports Nutrition Inc. and its affiliates"},{"label":"Headcount","value":"terminating, effective, as applicable, commencing September 14, 2023 and on an ongoing basis, 181 employees who were emp"}],"fact_type":"restructuring_charge"},{"claim_id":"d972686641b27934e7e1ad526d16ea359e00adda","claim":"Canopy Growth Corp announced a impairment with charges of the Company expects to incur an asset impairment charge of between approximately CDN$100-$130 million in the second quarter of fiscal year 2024 under generally affecting BioSteel Entities.","evidence_excerpt":"In conjunction with the CCAA process, the Company expects to incur an asset impairment charge of between approximately CDN$100-$130 million in the second quarter of fiscal year 2024 under generally accepted accounting principles.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737927/000110465923100636/0001104659-23-100636-index.htm","confidence":0.95,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"impairment"},{"label":"Charge","value":"the Company expects to incur an asset impairment charge of between approximately CDN$100-$130 million in the second quarter of fiscal year 2024 under generally"},{"label":"Affected area","value":"BioSteel Entities"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}